BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8616031)

  • 1. Reverse transcriptase/polymerase chain reaction follow-up and minimal residual disease detection in t(1;19)-positive acute lymphoblastic leukaemia.
    Privitera E; Rivolta A; Ronchetti D; Mosna G; Giudici G; Biondi A
    Br J Haematol; 1996 Mar; 92(3):653-8. PubMed ID: 8616031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia.
    Gameiro P; Moreira I; Yetgin S; Papaioannou M; Potter MN; Prentice HG; Hoffbrand AV; Foroni L
    Br J Haematol; 2002 Dec; 119(3):685-96. PubMed ID: 12437645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of E2A gene in childhood acute lymphoblastic leukemia].
    Hayashi Y; Kikuchi A; Kobayashi S; Shikano T; Hanada R; Yamamoto K; Sotomatsu M; Ishimoto K; Sako M; Yamamori S
    Rinsho Ketsueki; 1994 Jan; 35(1):9-13. PubMed ID: 8139107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome.
    Lanza C; Gottardi E; Gaidano G; Vivenza C; Parziale A; Perfetto F; Fornaci M; Barisone E; Madon E; Basso G; Saglio G
    Leuk Res; 1996 May; 20(5):441-3. PubMed ID: 8683984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia.
    Privitera E; Kamps MP; Hayashi Y; Inaba T; Shapiro LH; Raimondi SC; Behm F; Hendershot L; Carroll AJ; Baltimore D
    Blood; 1992 Apr; 79(7):1781-8. PubMed ID: 1348433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17;19)(q22;p13) acute lymphoblastic leukemia.
    Devaraj PE; Foroni L; Sekhar M; Butler T; Wright F; Mehta A; Samson D; Prentice HG; Hoffbrand AV; Secker-Walker LM
    Leukemia; 1994 Jul; 8(7):1131-8. PubMed ID: 7518549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses.
    Izraeli S; Janssen JW; Haas OA; Harbott J; Brok-Simoni F; Walther JU; Kovar H; Henn T; Ludwig WD; Reiter A
    Leukemia; 1993 May; 7(5):671-8. PubMed ID: 8483319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes.
    Devaraj PE; Foroni L; Janossy G; Hoffbrand AV; Secker-Walker LM
    Leukemia; 1995 May; 9(5):821-5. PubMed ID: 7769844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.
    Hunger SP; Fall MZ; Camitta BM; Carroll AJ; Link MP; Lauer SJ; Mahoney DH; Pullen DJ; Shuster JJ; Steuber CP; Cleary ML
    Blood; 1998 Feb; 91(3):1021-8. PubMed ID: 9446665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of residual disease monitoring by polymerase chain reaction in patients with ALL-1/AF-4 positive-acute lymphoblastic leukaemia.
    Cimino G; Elia L; Rivolta A; Rapanotti MC; Rossi V; Alimena G; Annino L; Canaani E; Lo Coco F; Biondi A
    Br J Haematol; 1996 Mar; 92(3):659-64. PubMed ID: 8616032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia].
    Gao C; Li ZG; Zhao W; Wu MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):569-73. PubMed ID: 18549631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia.
    Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonmundsson G; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
    Leukemia; 2005 Jan; 19(1):165-9. PubMed ID: 15526029
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia.
    Siraj AK; Ozbek U; Sazawal S; Sirma S; Timson G; Al-Nasser A; Bhargava M; El Solh H; Bhatia K; Gutiérrez MI
    Clin Cancer Res; 2002 Dec; 8(12):3832-40. PubMed ID: 12473597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL).
    Privitera E; Luciano A; Ronchetti D; Aricò M; Santostasi T; Basso G; Biondi A
    Leukemia; 1994 Apr; 8(4):554-9. PubMed ID: 8152250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
    Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features.
    Foa R; Vitale A; Mancini M; Cuneo A; Mecucci C; Elia L; Lombardo R; Saglio G; Torelli G; Annino L; Specchia G; Damasio E; Recchia A; Di Raimondo F; Morra E; Volpe E; Tafuri A; Fazi P; Hunger SP; Mandelli F
    Br J Haematol; 2003 Feb; 120(3):484-7. PubMed ID: 12580965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of prognostic significant translocations in childhood acute lymphoblastic leukaemia by one-step multiplex reverse transcription polymerase chain reaction.
    Cerveira N; Ferreira S; Dória S; Veiga I; Ferreira F; Mariz JM; Marques M; Castedo S
    Br J Haematol; 2000 Jun; 109(3):638-40. PubMed ID: 10886216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.